NASDAQ:TRHC - Tabula Rasa HealthCare Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$64.76 -0.47 (-0.72 %)
(As of 11/13/2018 04:00 PM ET)
Previous Close$65.23
Today's Range$64.51 - $67.31
52-Week Range$27.25 - $91.16
Volume152,213 shs
Average Volume346,386 shs
Market Capitalization$1.49 billion
P/E Ratio-1,619.00
Dividend YieldN/A
Beta2.58
Tabula Rasa HealthCare, Inc. operates as a healthcare technology company in the United States. It offers medication risk management, pharmacy cost management, and medicare risk adjustment services. The company offers its technology-enabled products and services to prescribers, pharmacists, and healthcare organizations for medication risk management and risk adjustment. Tabula Rasa HealthCare, Inc. was founded in 2009 and is headquartered in Moorestown, New Jersey.

Receive TRHC News and Ratings via Email

Sign-up to receive the latest news and ratings for TRHC and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry Business services, not elsewhere classified
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:TRHC
Previous Symbol
CUSIPN/A
Phone866-648-2767

Debt

Debt-to-Equity Ratio0.28
Current Ratio0.49
Quick Ratio0.46

Price-To-Earnings

Trailing P/E Ratio-1,619.00
Forward P/E Ratio154.19
P/E Growth6.89

Sales & Book Value

Annual Sales$134.55 million
Price / Sales9.85
Cash Flow$0.4436 per share
Price / Cash145.98
Book Value$6.86 per share
Price / Book9.44

Profitability

EPS (Most Recent Fiscal Year)($0.04)
Net Income$14.29 million
Net Margins-13.49%
Return on Equity7.63%
Return on Assets3.85%

Miscellaneous

Employees536
Outstanding Shares20,470,000
Market Cap$1.49 billion
OptionableOptionable

Tabula Rasa HealthCare (NASDAQ:TRHC) Frequently Asked Questions

What is Tabula Rasa HealthCare's stock symbol?

Tabula Rasa HealthCare trades on the NASDAQ under the ticker symbol "TRHC."

How were Tabula Rasa HealthCare's earnings last quarter?

Tabula Rasa HealthCare Inc (NASDAQ:TRHC) issued its quarterly earnings results on Tuesday, November, 6th. The company reported $0.26 earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of $0.19 by $0.07. The company had revenue of $54.42 million for the quarter, compared to analyst estimates of $52.87 million. Tabula Rasa HealthCare had a negative net margin of 13.49% and a positive return on equity of 7.63%. The business's revenue for the quarter was up 66.3% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.08 earnings per share. View Tabula Rasa HealthCare's Earnings History.

When is Tabula Rasa HealthCare's next earnings date?

Tabula Rasa HealthCare is scheduled to release their next quarterly earnings announcement on Monday, March 11th 2019. View Earnings Estimates for Tabula Rasa HealthCare.

What guidance has Tabula Rasa HealthCare issued on next quarter's earnings?

Tabula Rasa HealthCare updated its FY 2018 earnings guidance on Tuesday, November, 6th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $200-205 million, compared to the consensus revenue estimate of $198.41 million.Tabula Rasa HealthCare also updated its Q4 2018 guidance to EPS.

What price target have analysts set for TRHC?

10 brokerages have issued 12-month price targets for Tabula Rasa HealthCare's stock. Their predictions range from $47.00 to $100.00. On average, they anticipate Tabula Rasa HealthCare's stock price to reach $82.4444 in the next twelve months. This suggests a possible upside of 27.3% from the stock's current price. View Analyst Price Targets for Tabula Rasa HealthCare.

What is the consensus analysts' recommendation for Tabula Rasa HealthCare?

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Tabula Rasa HealthCare in the last year. There are currently 1 hold rating and 9 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Tabula Rasa HealthCare.

What are Wall Street analysts saying about Tabula Rasa HealthCare stock?

Here are some recent quotes from research analysts about Tabula Rasa HealthCare stock:
  • 1. According to Zacks Investment Research, "Tabula Rasa HealthCare, Inc. is a provider of patient-specific, data-driven technology and solutions which enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations, lower healthcare costs and manage risk. The company's cloud-based software applications including EireneRx and MedWise Advisor which provide solutions to payers, providers and other healthcare organizations. Tabula Rasa HealthCare, Inc. is based in NJ, United States. " (11/10/2018)
  • 2. Cantor Fitzgerald analysts commented, ". We reiterate our Overweight rating and $99 12-month price target on TRHC shares. Rasa reported solid third quarter results, which were generally above our estimates and FactSet consensus. The company’s top-line beat was driven by recent acquisitions and higher pharmacy cost management (PCM) revenue due to a change regarding TRHC’s data aggregation partner. The company’s recent acquisitions contributed modestly to revenue. While TRHC provided general comments regarding 2019, it did not provide full guidance." (11/6/2018)

Has Tabula Rasa HealthCare been receiving favorable news coverage?

Media stories about TRHC stock have been trending somewhat positive recently, InfoTrie Sentiment Analysis reports. InfoTrie ranks the sentiment of press coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Tabula Rasa HealthCare earned a coverage optimism score of 1.5 on InfoTrie's scale. They also assigned news headlines about the company a news buzz of 10.0 out of 10, meaning that recent press coverage is extremely likely to have an effect on the stock's share price in the next few days.

Who are some of Tabula Rasa HealthCare's key competitors?

Who are Tabula Rasa HealthCare's key executives?

Tabula Rasa HealthCare's management team includes the folowing people:
  • Dr. Calvin H. Knowlton, Co-Founder, Chairman & CEO (Age 68)
  • Dr. Orsula V. Knowlton BScPharm, PharmD, MBA, Co-Founder, Pres, Chief Marketing & New Bus. Devel. Officer and Director (Age 49)
  • Mr. Brian W. Adams, CFO & Sec. (Age 36)
  • Mr. Michael Greenhalgh BScPharm, RPh, Chief Operating Officer
  • Ms. Andrea Carolan Speers, Corp. Controller & Chief Accounting Officer (Age 37)

When did Tabula Rasa HealthCare IPO?

(TRHC) raised $60 million in an initial public offering (IPO) on Thursday, September 29th 2016. The company issued 4,300,000 shares at $13.00-$15.00 per share. Wells Fargo Securities, UBS Investment Bank and Piper Jaffray served as the underwriters for the IPO and Baird and Stifel were co-managers.

Who are Tabula Rasa HealthCare's major shareholders?

Tabula Rasa HealthCare's stock is owned by a variety of of retail and institutional investors. Top institutional investors include BlackRock Inc. (12.65%), Jennison Associates LLC (3.74%), NN Investment Partners Holdings N.V. (3.31%), Bank of New York Mellon Corp (1.28%), Peregrine Capital Management LLC (1.20%) and Braun Stacey Associates Inc. (1.13%). Company insiders that own Tabula Rasa HealthCare stock include Brian W Adams, Bruce Luehrs, Calvin H Knowlton, Glen R Bressner, Gordon Tunstall, Growth Fund 1Q Lp Originate and Orsula V Knowlton. View Institutional Ownership Trends for Tabula Rasa HealthCare.

Which major investors are selling Tabula Rasa HealthCare stock?

TRHC stock was sold by a variety of institutional investors in the last quarter, including Emerald Advisers Inc. PA, JPMorgan Chase & Co., JPMorgan Chase & Co., Emerald Mutual Fund Advisers Trust, Braun Stacey Associates Inc., Bollard Group LLC, Wasatch Advisors Inc. and Tygh Capital Management Inc.. Company insiders that have sold Tabula Rasa HealthCare company stock in the last year include Bruce Luehrs, Calvin H Knowlton, Gordon Tunstall, Growth Fund 1Q Lp Originate and Orsula V Knowlton. View Insider Buying and Selling for Tabula Rasa HealthCare.

Which major investors are buying Tabula Rasa HealthCare stock?

TRHC stock was purchased by a variety of institutional investors in the last quarter, including BlackRock Inc., NN Investment Partners Holdings N.V., Wells Fargo & Company MN, Eagle Asset Management Inc., Pictet Asset Management Ltd., Bank of New York Mellon Corp, Allianz Asset Management GmbH and Mutual of America Capital Management LLC. Company insiders that have bought Tabula Rasa HealthCare stock in the last two years include Brian W Adams and Glen R Bressner. View Insider Buying and Selling for Tabula Rasa HealthCare.

How do I buy shares of Tabula Rasa HealthCare?

Shares of TRHC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Tabula Rasa HealthCare's stock price today?

One share of TRHC stock can currently be purchased for approximately $64.76.

How big of a company is Tabula Rasa HealthCare?

Tabula Rasa HealthCare has a market capitalization of $1.49 billion and generates $134.55 million in revenue each year. The company earns $14.29 million in net income (profit) each year or ($0.04) on an earnings per share basis. Tabula Rasa HealthCare employs 536 workers across the globe.

What is Tabula Rasa HealthCare's official website?

The official website for Tabula Rasa HealthCare is http://www.tabularasahealthcare.com.

How can I contact Tabula Rasa HealthCare?

Tabula Rasa HealthCare's mailing address is 228 STRAWBRIDGE DRIVE SUITE 100, MOORESTOWN NJ, 08057. The company can be reached via phone at 866-648-2767 or via email at [email protected]


MarketBeat Community Rating for Tabula Rasa HealthCare (NASDAQ TRHC)

Community Ranking:  2.7 out of 5 (star star)
Outperform Votes:  186 (Vote Outperform)
Underperform Votes:  157 (Vote Underperform)
Total Votes:  343
MarketBeat's community ratings are surveys of what our community members think about Tabula Rasa HealthCare and other stocks. Vote "Outperform" if you believe TRHC will outperform the S&P 500 over the long term. Vote "Underperform" if you believe TRHC will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 11/13/2018 by MarketBeat.com Staff

Featured Article: Dollar Cost Averaging

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel